Cargando…
Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells
INTRODUCTION: Overexpression on plasma membrane of human epidermal growth factor receptor 2 (HER2) is reported in 25% to 30% of breast cancers. Heterodimer formation with cognate members of the epidermal growth factor receptor (EGFR) family, such as HER3 and EGFR, activates abnormal cell-signalling...
Autores principales: | Paris, Luisa, Cecchetti, Serena, Spadaro, Francesca, Abalsamo, Laura, Lugini, Luana, Pisanu, Maria Elena, Iorio, Egidio, Natali, Pier Giorgio, Ramoni, Carlo, Podo, Franca |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917016/ https://www.ncbi.nlm.nih.gov/pubmed/20462431 http://dx.doi.org/10.1186/bcr2575 |
Ejemplares similares
-
Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells
por: Abalsamo, Laura, et al.
Publicado: (2012) -
Activation of Phosphatidylcholine-Specific Phospholipase C in Breast and Ovarian Cancer: Impact on MRS-Detected Choline Metabolic Profile and Perspectives for Targeted Therapy
por: Podo, Franca, et al.
Publicado: (2016) -
Phosphatidylcholine-specific phospholipase C inhibition reduces HER2-overexpression, cell proliferation and in vivo tumor growth in a highly tumorigenic ovarian cancer model
por: Paris, Luisa, et al.
Publicado: (2017) -
Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma
por: Cecchetti, Serena, et al.
Publicado: (2015) -
Phosphatidylcholine-specific phospholipase C inhibition down- regulates CXCR4 expression and interferes with proliferation, invasion and glycolysis in glioma cells
por: Mercurio, Laura, et al.
Publicado: (2017)